Relationship between Initial Lactate Level with Mortality in Children with Sepsis and Septic Shock: A Comparison with the PRISM-3 Score

Abstract

Objective Sepsis and septic shock are leading causes of mortality and morbidity in intensive care units. Our study aimed to compare the pediatric risk of mortality (PRISM-3) score, which is used for predicting mortality risk among critically ill patients in pediatric intensive care units, with laboratory parameters, particularly lactate parameters.

Methods This study included 38 patients aged 1 month to 18 years who were managed for sepsis and septic shock in a pediatric intensive care unit. Lactate, D-dimer, troponin T, and N-terminal prohormone of brain natriuretic peptide levels were measured at the 0th and 24th hours. The patients were divided into survivors and nonsurvivors and those with septic shock and those without.

Results There were a total of 38 patients with a median age of 12 months, of whom 17 (44.7%) were males and 21 (55.3%) were females. Six (15.8%) patients died within 7 days after the diagnosis. Nonsurvivors had significantly higher median values of PRISM-3 (p = 0.002), C-reactive protein (p = 0.046), and partial arterial carbon dioxide pressure (p = 0.041). PRISM-3 showed a good discriminatory power (area under the curve [AUROC] = 0.878; p < 0.0001) and baseline lactate level showed a moderate level of discriminatory power (AUROC = 0.734 p = 0.0254) for early mortality within 7 days.

Conclusion PRISM-3 and baseline lactate predict early mortality in children with sepsis and septic shock. We suggest that adding lactate, which is not included in the PRISM-3 score, to the score may increase the score's predictive ability for mortality. We believe, however, that randomized, controlled, multicenter studies with larger sample sizes should be conducted to test this hypothesis.

Keywords

sepsis - septic shock - child - PRISM-3 - lactate parameters

Author Contributions

G.B. and M.A. were responsible for study conception and design. Data collection was done by G.B., M.A., and H.S. Analysis and interpretation of results were done by G.B. and M.A. Draft manuscript preparation was done by G.B., M.A., and H.S. All the authors reviewed the results and approved the final version of the manuscript.

Ethical Approval

This study was approved by Kayseri City Hospital Clinical Research Ethics Committee (April/2020; No. 50).

Consent for Publication

This manuscript is not under simultaneous consideration by any other publication. All authors have approved the final manuscript and take full responsibility for the manuscript.

Publikationsverlauf

Eingereicht: 21. November 2022

Angenommen: 26. Januar 2023

Artikel online veröffentlicht:
30. März 2023

• References

• 1 Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med 2018; 6 (03) 223-230
• 2 Schlapbach LJ, Straney L, Alexander J. et al; ANZICS Paediatric Study Group. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis 2015; 15 (01) 46-54
• 3 Kaur A, Kaur G, Dhir SK. et al. Pediatric Risk of Mortality III score: predictor of mortality and hospital stay in pediatric intensive care unit. J Emerg Trauma Shock 2020; 13 (02) 146-150
• 4 Alkhalifah AS, AlSoqati A, Zahraa J. Performance of Pediatric Risk of Mortality III and Pediatric Index of Mortality III scores in tertiary pediatric intensive unit in Saudi Arabia. Front Pediatr 2022; 10: 926686
• 5 Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care 2014; 18 (05) 503
• 6 Sharma A, Sikka M, Gomber S, Sharma S. Plasma fibrinogen and D-dimer in children with sepsis: a single-center experience. Iran J Pathol 2018; 13 (02) 272-275
• 7 Khera D, Toteja N, Singh S. et al. Is there a role of Presepsin as a novel biomarker in pediatric sepsis?. Indian J Crit Care Med 2022; 26 (06) 712-716
• 8 Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6 (01) 2-8
• 9 Dellinger RP, Levy MM, Rhodes A. et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (02) 580-637
• 10 Allen M. Lactate and acid base as a hemodynamic monitor and markers of cellular perfusion. Pediatr Crit Care Med 2011; 12 (4, Suppl): S43-S49
• 11 Marikar D, Babu P, Fine-Goulden M. How to interpret lactate. Arch Dis Child Educ Pract Ed 2021; 106 (03) 167-171
• 12 Mirza S, Malik L, Ahmed J. et al. Accuracy of pediatric risk of mortality (PRISM) III score in predicting mortality outcomes in a pediatric intensive care unit in Karachi. Cureus 2020; 12 (03) e7489
• 13 Bai Z, Zhu X, Li M. et al. Effectiveness of predicting in-hospital mortality in critically ill children by assessing blood lactate levels at admission. BMC Pediatr 2014; 14: 83
• 14 Mikkelsen ME, Miltiades AN, Gaieski DF. et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009; 37 (05) 1670-1677
• 15 Scott HF, Brou L, Deakyne SJ, Kempe A, Fairclough DL, Bajaj L. Association between early lactate levels and 30- day mortality in clinically suspected sepsis in children. JAMA Pediatr 2017; 171 (03) 249-255
• 16 Hatherill M, McIntyre AG, Wattie M, Murdoch IA. Early hyperlactataemia in critically ill children. Intensive Care Med 2000; 26 (03) 314-318
• 17 Alam A, Gupta S. Lactate measurements and their association with mortality in pediatric severe sepsis in india: evidence that 6-hour level performs best. J Intensive Care Med 2021; 36 (04) 443-450
• 18 Gorgis N, Asselin JM, Fontana C, Heidersbach RS, Flori HR, Ward SL. Evaluation of the association of early elevated lactate with outcomes in children with severe sepsis or septic shock. Pediatr Emerg Care 2019; 35 (10) 661-665
• 19 Kim YA, Ha EJ, Jhang WK, Park SJ. Early blood lactate area as a prognostic marker in pediatric septic shock. Intensive Care Med 2013; 39 (10) 1818-1823
• 20 Nguyen HB, Rivers EP, Knoblich BP. et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32 (08) 1637-1642
• 21 Choudhary R, Sitaraman S, Choudhary A. Lactate clearance as the predictor of outcome in pediatric septic shock. J Emerg Trauma Shock 2017; 10 (02) 55-59
• 22 Jat KR, Jhamb U, Gupta VK. Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med 2011; 15 (02) 102-107
• 23 Horvat CM, Fabio A, Nagin DS. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Mortality risk in pediatric sepsis based on C-reactive protein and ferritin levels. Pediatr Crit Care Med 2022; 23 (12) 968-979
• 24 Tonial CT, Costa CAD, Andrades GRH. et al. Performance of prognostic markers in pediatric sepsis. J Pediatr (Rio J) 2021; 97 (03) 287-294